DK0839806T3 - Substituerede tricykliske forbindelser - Google Patents
Substituerede tricykliske forbindelserInfo
- Publication number
- DK0839806T3 DK0839806T3 DK97308645T DK97308645T DK0839806T3 DK 0839806 T3 DK0839806 T3 DK 0839806T3 DK 97308645 T DK97308645 T DK 97308645T DK 97308645 T DK97308645 T DK 97308645T DK 0839806 T3 DK0839806 T3 DK 0839806T3
- Authority
- DK
- Denmark
- Prior art keywords
- tricyclic compounds
- substituted tricyclic
- substituted
- compounds
- tricyclic
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2984996P | 1996-10-30 | 1996-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0839806T3 true DK0839806T3 (da) | 2003-10-27 |
Family
ID=21851210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97308645T DK0839806T3 (da) | 1996-10-30 | 1997-10-29 | Substituerede tricykliske forbindelser |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0839806B1 (xx) |
| JP (1) | JP2001503055A (xx) |
| KR (1) | KR20000049210A (xx) |
| CN (1) | CN1233176A (xx) |
| AR (1) | AR010050A1 (xx) |
| AT (1) | ATE244703T1 (xx) |
| AU (1) | AU734096B2 (xx) |
| BR (1) | BR9713261A (xx) |
| CA (1) | CA2269203A1 (xx) |
| CO (1) | CO4920250A1 (xx) |
| CZ (1) | CZ136899A3 (xx) |
| DE (1) | DE69723393T2 (xx) |
| DK (1) | DK0839806T3 (xx) |
| EA (1) | EA003992B1 (xx) |
| ES (1) | ES2202560T3 (xx) |
| ID (1) | ID18685A (xx) |
| IL (1) | IL129481A0 (xx) |
| NO (1) | NO314899B1 (xx) |
| NZ (1) | NZ335246A (xx) |
| PE (1) | PE10999A1 (xx) |
| PL (1) | PL332896A1 (xx) |
| PT (1) | PT839806E (xx) |
| TR (1) | TR199900956T2 (xx) |
| TW (1) | TW513428B (xx) |
| WO (1) | WO1998018464A1 (xx) |
| YU (1) | YU19299A (xx) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1011670A4 (en) * | 1997-08-28 | 2004-10-27 | Lilly Co Eli | PROCESS FOR TREATING NON-RHUMATOID POLYARTHRITIS |
| KR20010042307A (ko) | 1998-03-31 | 2001-05-25 | 시오노 요시히코 | 피롤로[1,2-ａ]피라진 ｓＰＬＡ2 억제제 |
| DZ2769A1 (fr) * | 1998-04-17 | 2003-12-01 | Lilly Co Eli | Composés tricycliques substitués. |
| IL129484A0 (en) * | 1998-04-17 | 2000-02-29 | Lilly Co Eli | Substituted tricyclics |
| WO1999057100A1 (en) | 1998-05-01 | 1999-11-11 | Eli Lilly And Company | Spla2 inhibitor compounds for treatment of disease |
| JP4544446B2 (ja) | 1998-05-21 | 2010-09-15 | 塩野義製薬株式会社 | ｓＰＬＡ２阻害作用を有するピロロ［１，２−ｂ］ピリダジン誘導体 |
| DE69931963D1 (de) | 1998-10-14 | 2006-07-27 | Shionogi & Co | Spla2-inhibitoren zur behandlung von ischämischen reperfusionsschäden |
| DE69910432D1 (de) * | 1998-12-22 | 2003-09-18 | Lilly Co Eli | Substituierte pyrroloindole |
| WO2001005789A1 (fr) | 1999-07-19 | 2001-01-25 | Shionogi & Co., Ltd. | Composes tricycliques a action inhibitrice a l'encontre de spla¿2? |
| AU6023200A (en) | 1999-08-02 | 2001-02-19 | Shionogi & Co., Ltd. | Tricyclic compounds having spla2-inhibitory activities |
| WO2001014378A1 (fr) | 1999-08-23 | 2001-03-01 | Shionogi & Co., Ltd. | DERIVES DE PYRROLOTRIAZINE A ACTIVITES INHIBANT sPLA¿2? |
| MY125942A (en) | 1999-09-07 | 2006-09-29 | Upjohn Co | Aminoalkoxy carbazoles for the treatment of cns diseases |
| US6756376B1 (en) | 1999-11-15 | 2004-06-29 | Shionogi & Co., Ltd. | Tricyclic azaindolizine derivatives having an sPLA2-inhibitory activities |
| JP2003519198A (ja) * | 2000-01-06 | 2003-06-17 | イーライ・リリー・アンド・カンパニー | 炎症性疾患および呼吸器疾患の処置のための併用療法 |
| US6967200B2 (en) | 2000-06-29 | 2005-11-22 | Shionogi & Co., Ltd. | Remedies for cirrhosis |
| WO2002000621A1 (fr) | 2000-06-29 | 2002-01-03 | Shionogi & Co., Ltd. | Composes inhibiteurs de la spla2 de type x |
| WO2002050034A2 (en) * | 2000-12-18 | 2002-06-27 | Eli Lilly And Company | Tetracyclic carbazole derivates and their use as spla2 inhibitors |
| TWI314457B (xx) * | 2001-03-19 | 2009-09-11 | Shionogi & Co | |
| AUPS282602A0 (en) | 2002-06-07 | 2002-06-27 | Garvan Institute Of Medical Research | Method of inhibiting cell proliferation |
| CN101048402B (zh) | 2004-10-29 | 2011-11-09 | 泽里新药工业株式会社 | 咔唑衍生物、其溶剂合物或其药学上允许的盐 |
| ES2924728T3 (es) | 2015-06-15 | 2022-10-10 | Raziel Therapeutics Ltd | Derivados de carbazol para el tratamiento de enfermedades fibróticas, así como de síntomas y afecciones relacionados con las mismas |
| CN112409493B (zh) * | 2020-08-12 | 2022-09-30 | 浙江工业大学 | 一种重组融合酶及其在乙醛酸甲酯合成中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3479391A (en) * | 1966-10-03 | 1969-11-18 | Squibb & Sons Inc | Delta**3,14-17alpha-hydroxy-norprogesterone and esters |
| US3939177A (en) * | 1972-11-22 | 1976-02-17 | Sterling Drug Inc. | 4-Aminomethyl-9-benzyl-1,2,3,4-tetrahydrocarbazoles |
| US3979391A (en) * | 1972-11-22 | 1976-09-07 | Sterling Drug Inc. | 1,2,3,4-Tetrahydrocarbazoles |
| US5420289A (en) * | 1989-10-27 | 1995-05-30 | American Home Products Corporation | Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase |
| IL109311A0 (en) * | 1993-04-16 | 1994-07-31 | Lilly Co Eli | 1H-indole-3-acetamide sPla2 inhibitors |
| IL109309A (en) * | 1993-04-16 | 2000-06-29 | Lilly Co Eli | 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them |
-
1997
- 1997-10-23 JP JP10520585A patent/JP2001503055A/ja active Pending
- 1997-10-23 NZ NZ335246A patent/NZ335246A/en unknown
- 1997-10-23 EA EA199900305A patent/EA003992B1/ru not_active IP Right Cessation
- 1997-10-23 IL IL12948197A patent/IL129481A0/xx unknown
- 1997-10-23 CN CN97198834A patent/CN1233176A/zh active Pending
- 1997-10-23 AU AU51494/98A patent/AU734096B2/en not_active Ceased
- 1997-10-23 TR TR1999/00956T patent/TR199900956T2/xx unknown
- 1997-10-23 KR KR1019990703309A patent/KR20000049210A/ko not_active Application Discontinuation
- 1997-10-23 BR BR9713261-6A patent/BR9713261A/pt unknown
- 1997-10-23 YU YU19299A patent/YU19299A/sh unknown
- 1997-10-23 CZ CZ991368A patent/CZ136899A3/cs unknown
- 1997-10-23 CA CA002269203A patent/CA2269203A1/en not_active Abandoned
- 1997-10-23 PL PL97332896A patent/PL332896A1/xx unknown
- 1997-10-23 WO PCT/US1997/019183 patent/WO1998018464A1/en not_active Application Discontinuation
- 1997-10-24 PE PE1997000950A patent/PE10999A1/es not_active Application Discontinuation
- 1997-10-27 ID IDP973534A patent/ID18685A/id unknown
- 1997-10-28 CO CO97063171A patent/CO4920250A1/es unknown
- 1997-10-28 AR ARP970104997A patent/AR010050A1/es active IP Right Grant
- 1997-10-29 PT PT97308645T patent/PT839806E/pt unknown
- 1997-10-29 ES ES97308645T patent/ES2202560T3/es not_active Expired - Lifetime
- 1997-10-29 EP EP97308645A patent/EP0839806B1/en not_active Expired - Lifetime
- 1997-10-29 DK DK97308645T patent/DK0839806T3/da active
- 1997-10-29 AT AT97308645T patent/ATE244703T1/de active
- 1997-10-29 DE DE69723393T patent/DE69723393T2/de not_active Expired - Lifetime
- 1997-10-30 TW TW086116217A patent/TW513428B/zh not_active IP Right Cessation
-
1999
- 1999-04-16 NO NO19991831A patent/NO314899B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0839806A1 (en) | 1998-05-06 |
| TR199900956T2 (xx) | 1999-07-21 |
| CA2269203A1 (en) | 1998-05-07 |
| EA003992B1 (ru) | 2003-12-25 |
| KR20000049210A (ko) | 2000-07-25 |
| CN1233176A (zh) | 1999-10-27 |
| DE69723393D1 (de) | 2003-08-14 |
| AU734096B2 (en) | 2001-06-07 |
| DE69723393T2 (de) | 2004-06-09 |
| AR010050A1 (es) | 2000-05-17 |
| TW513428B (en) | 2002-12-11 |
| NO314899B1 (no) | 2003-06-10 |
| PL332896A1 (en) | 1999-10-25 |
| WO1998018464A1 (en) | 1998-05-07 |
| BR9713261A (pt) | 2000-03-28 |
| JP2001503055A (ja) | 2001-03-06 |
| YU19299A (sh) | 2000-03-21 |
| ES2202560T3 (es) | 2004-04-01 |
| NZ335246A (en) | 2001-09-28 |
| EP0839806B1 (en) | 2003-07-09 |
| CZ136899A3 (cs) | 1999-09-15 |
| NO991831D0 (no) | 1999-04-16 |
| IL129481A0 (en) | 2000-02-29 |
| ATE244703T1 (de) | 2003-07-15 |
| PT839806E (pt) | 2003-11-28 |
| NO991831L (no) | 1999-06-21 |
| CO4920250A1 (es) | 2000-05-29 |
| PE10999A1 (es) | 1999-02-10 |
| ID18685A (id) | 1998-04-30 |
| EA199900305A1 (ru) | 1999-12-29 |
| AU5149498A (en) | 1998-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID19609A (id) | Senyawa-senyawa heterosiklik | |
| ID19403A (id) | Senyawa-senyawa heterosiklik | |
| ID16152A (id) | Senyawa-senyawa triaril | |
| ID15904A (id) | Senyawa-senyawa tiofenopirimidina | |
| BR9710352A (pt) | Compostos piridilpirrole | |
| NO991821D0 (no) | Substituerte tricykliske forbindelser | |
| DK0839806T3 (da) | Substituerede tricykliske forbindelser | |
| DE69716924T2 (de) | Phosphonat-nukleotid-verbindungen | |
| LV12207A (lv) | Tricikliski savienojumi | |
| EE9800430A (et) | Uued ühendid | |
| BR9705635A (pt) | Compostos | |
| NO991823D0 (no) | Substituerte tricykliske forbindelser | |
| DK0923594T3 (da) | Bromotiacumicinforbindelser | |
| BR9711033A (pt) | P-trifluormetilfeniluracilos substituidos | |
| DE69709659T2 (de) | Halopropargyl-einschlussverbindungen | |
| DE59707428D1 (de) | Substituierte 1-methyl-3-benzyluracile | |
| ATE275146T1 (de) | Substituierte pyrazol-3-ylbenzazole | |
| EE9900012A (et) | Uudsed ühendid | |
| BR9709466A (pt) | Feniluracilas substituídas | |
| DE69719054D1 (de) | Trizyclische carbapenem-verbindungen | |
| SE9601599D0 (sv) | Novel compounds | |
| ID17103A (id) | Senyawa-senyawa sulfonamida | |
| SE9600275D0 (sv) | Compounds | |
| SE9603300D0 (sv) | Compounds | |
| SE9603464D0 (sv) | New compounds |